These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853 [TBL] [Abstract][Full Text] [Related]
30. Time to ferry heart failure onto new shores: the need to effectively customize long-term therapy. Parrinello G; Torres D; Paterna S; Licata G; Di Pasquale P Am Heart J; 2011 Mar; 161(3):e13-4; author reply e15. PubMed ID: 21392592 [No Abstract] [Full Text] [Related]
31. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259 [TBL] [Abstract][Full Text] [Related]
32. High furosemide dose has detrimental effects on survival of patients with stable heart failure. Kapelios CJ; Kaldara E; Ntalianis A; Sousonis V; Repasos E; Sfakianaki T; Vakrou S; Pantsios C; Nanas JN; Terrovitis JV Hellenic J Cardiol; 2015; 56(2):154-9. PubMed ID: 25854445 [TBL] [Abstract][Full Text] [Related]
33. The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial. Chávez-Iñiguez JS; Ibarra-Estrada M; Sánchez-Villaseca S; Romero-González G; Font-Yañez JJ; De la Torre-Quiroga A; de Quevedo AA; Romero-Muñóz A; Maggiani-Aguilera P; Chávez-Alonso G; Gómez-Fregoso J; García-García G BMC Nephrol; 2022 Jan; 23(1):3. PubMed ID: 34979962 [TBL] [Abstract][Full Text] [Related]
34. Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure. Chuen MJ; MacFadyen RJ Am J Cardiol; 2006 Nov; 98(10):1416-7. PubMed ID: 17134642 [No Abstract] [Full Text] [Related]
35. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. Ng TM; Hshieh S; Chan CY; Elkayam U J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091 [TBL] [Abstract][Full Text] [Related]
36. Subcutaneous furosemide. Goenaga MA; Millet M; Sánchez E; Garde C; Carrera JA; Arzellus E Ann Pharmacother; 2004 Oct; 38(10):1751. PubMed ID: 15340122 [No Abstract] [Full Text] [Related]
37. Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure. Picazo Sánchez M; Castillo Lorenzo MN; Cuxart Pérez M; Sans Lorman R Nefrologia (Engl Ed); 2018; 38(4):438-439. PubMed ID: 29275931 [No Abstract] [Full Text] [Related]
38. The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. Parker JO Int J Cardiol; 1993 Jul; 40(3):221-7. PubMed ID: 8225657 [TBL] [Abstract][Full Text] [Related]
40. Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure. Ward MJ; Collins SP; Liu D; Froehle CM Int J Cardiol; 2018 Oct; 269():207-212. PubMed ID: 30041982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]